BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE | N021929 | ASTRAZENECA LP
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
AstraZeneca AB et al v. Mylan Pharmaceuticals Inc. et al 5 patentsANDA 211699budesonide/formoterol fumarate dihydrate | WVND | 2022-04-26 | Terminated 2023-03-08 | — |
| WVND | 2019-11-04 | Terminated 2023-03-08 | — | |
AstraZeneca AB et al v. Teva Pharmaceuticals USA, Inc. 4 patentsANDA 212212budesonide/formoterol fumarate dihydrate | D. Del. | 2018-10-26 | Terminated 2019-12-04 | — |
AstraZeneca AB et al v. Mylan Pharmaceuticals Inc. et al 4 patentsANDA 211699budesonide/formoterol fumarate dihydrate | WVND | 2018-10-12 | Terminated 2023-03-08 | — |
| D. Del. | 2018-10-11 | Terminated 2019-11-04 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$25.47
per gm
Lowest NADAC/Unit
$15.53
per gm
Brand NDCs
4
Generic NDCs
2
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 00186037028SYMBICORT 160-4.5 MCG INHALER | $25.47 | GM | Brand | — | 2026-10-21 |
| 00186037020SYMBICORT 160-4.5 MCG INHALER | $21.98 | GM | Brand | $17.32 | 2026-10-21 |
| 00186037228SYMBICORT 80-4.5 MCG INHALER | $19.29 | GM | Brand | — | 2026-10-21 |
| 00186037220SYMBICORT 80-4.5 MCG INHALER | $19.25 | GM | Brand | $15.53 | 2026-10-21 |
| 00310737020BUDESONIDE-FORMOTEROL 160-4.5 | $17.32 | GM | Generic | — | 2026-10-21 |
| 00310737220BUDESONIDE-FORMOTEROL 80-4.5 | $15.53 | GM | Generic | — | 2026-10-21 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.